PT Jayamas Medica Industri Tbk (IDX:OMED)
250.00
-2.00 (-0.79%)
Mar 17, 2026, 4:14 PM WIB
IDX:OMED Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,063,817 | 1,885,822 | 1,736,990 | 1,739,054 | 2,226,573 | |
Revenue Growth (YoY) | 9.44% | 8.57% | -0.12% | -21.89% | 11.63% |
Cost of Revenue | 1,346,321 | 1,261,846 | 1,184,990 | 1,176,045 | 1,322,544 |
Gross Profit | 717,496 | 623,976 | 552,000 | 563,010 | 904,030 |
Selling, General & Admin | 326,599 | 275,502 | 250,002 | 198,309 | 168,243 |
Other Operating Expenses | -18,502 | 3,016 | 1,842 | -7,542 | 2,951 |
Operating Expenses | 308,098 | 278,518 | 251,843 | 190,767 | 171,194 |
Operating Income | 409,398 | 345,458 | 300,156 | 372,243 | 732,836 |
Interest Expense | -17,876 | -19,768 | -19,581 | -20,805 | -21,840 |
Interest & Investment Income | - | 57,008 | 43,520 | 14,371 | 16,909 |
Currency Exchange Gain (Loss) | - | 11,911 | 1,654 | 6,704 | 1,445 |
Other Non Operating Income (Expenses) | 63,408 | -460.86 | -341.03 | -403.98 | -328.64 |
EBT Excluding Unusual Items | 454,929 | 394,148 | 325,409 | 372,109 | 729,020 |
Gain (Loss) on Sale of Assets | - | -121.48 | 35.59 | 0.04 | 179.92 |
Pretax Income | 454,929 | 394,026 | 325,444 | 372,109 | 729,200 |
Income Tax Expense | 85,986 | 70,074 | 64,462 | 81,602 | 158,821 |
Earnings From Continuing Operations | 368,943 | 323,952 | 260,982 | 290,507 | 570,379 |
Minority Interest in Earnings | -1,994 | -2,279 | -1,622 | -4,725 | -7,687 |
Net Income | 366,949 | 321,673 | 259,360 | 285,782 | 562,692 |
Net Income to Common | 366,949 | 321,673 | 259,360 | 285,782 | 562,692 |
Net Income Growth | 14.07% | 24.03% | -9.25% | -49.21% | -17.92% |
Shares Outstanding (Basic) | 27,041 | 27,059 | 27,059 | 27,059 | 27,059 |
Shares Outstanding (Diluted) | 27,041 | 27,059 | 27,059 | 27,059 | 27,059 |
Shares Change (YoY) | -0.07% | - | - | - | -1.44% |
EPS (Basic) | 13.57 | 11.89 | 9.59 | 10.56 | 20.80 |
EPS (Diluted) | 13.57 | 11.89 | 9.59 | 10.56 | 20.80 |
EPS Growth | 14.15% | 24.03% | -9.25% | -49.21% | -16.71% |
Free Cash Flow | 286,951 | 249,245 | -22,031 | 17,549 | 422,386 |
Free Cash Flow Per Share | 10.61 | 9.21 | -0.81 | 0.65 | 15.61 |
Dividend Per Share | - | 3.570 | 6.050 | - | 10.870 |
Dividend Growth | - | -40.99% | - | - | -36.06% |
Gross Margin | 34.77% | 33.09% | 31.78% | 32.37% | 40.60% |
Operating Margin | 19.84% | 18.32% | 17.28% | 21.40% | 32.91% |
Profit Margin | 17.78% | 17.06% | 14.93% | 16.43% | 25.27% |
Free Cash Flow Margin | 13.90% | 13.22% | -1.27% | 1.01% | 18.97% |
EBITDA | 460,005 | 388,670 | 334,660 | 392,559 | 752,142 |
EBITDA Margin | 22.29% | 20.61% | 19.27% | 22.57% | 33.78% |
D&A For EBITDA | 50,607 | 43,213 | 34,504 | 20,317 | 19,307 |
EBIT | 409,398 | 345,458 | 300,156 | 372,243 | 732,836 |
EBIT Margin | 19.84% | 18.32% | 17.28% | 21.40% | 32.91% |
Effective Tax Rate | 18.90% | 17.78% | 19.81% | 21.93% | 21.78% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.